Gastrointestinal Systems Market Size

  • Report ID: 4032
  • Published Date: Sep 26, 2023
  • Report Format: PDF, PPT

Gastrointestinal Systems Market Size

Gastrointestinal Radiofrequency Ablation Systems Market size is poised to reach USD 14 Billion by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024 – 2036. In the year 2023, the industry size of gastrointestinal radiofrequency ablation systems was USD 4 Billion. The growth of the market can be attributed to the growing incidence of cancer cases globally. RFA systems may become more popular as cancer rates rise since medical professionals are looking for less invasive ways to treat their patients. Globally over 6 million new instances of cancer will be reported among persons 80 years of age or older in 2050 which is more than 20% of all cancer cases.

In addition to these, factors that are believed to fuel the market growth of gastrointestinal radiofrequency ablation systems include the rise in technological advancements. For instance, RFA technology developments have resulted in the creation of more accurate and effective devices that can provide targeted energy to the damaged tissue with the least amount of harm to healthy tissue nearby. As a result, the method is now safer and more efficient, which may be causing RFA system demand to rise.

 


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4032
  • Published Date: Sep 26, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing preference for minimally invasive procedures and the growing prevalence of gastrointestinal diseases are the major factors driving the market growth.

The market size of gastrointestinal radiofrequency ablation systems is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 – 2035.

The major players in the market are ATRICURE, INC, Royal Philips, Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Japan Lifeline Co. Ltd, Medtronic Japan Co. Ltd, Olympus Corporation, Astellas Pharma Inc. and others

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample